Johnson & Johnson (NYSE: JNJ) reported its third quarter 2024 earnings outcomes as we speak.
Reported gross sales elevated 5.2% year-over-year to $22.5 billion.
GAAP earnings decreased 37.5% to $2.7 billion whereas EPS fell 34% to $1.11 in comparison with final 12 months. Adjusted EPS was down 9% to $2.42.
For full-year 2024, JNJ expects reported gross sales of $88.4-88.8 billion and adjusted EPS of $9.88-9.98.
(This story can be up to date shortly with an infographic)
Jonathan Raa | Nurphoto | Getty ImagesArtificial intelligence giant Anthropic shocked observers when it said Friday evening it disabled access...
SpaceX is allocating a smaller-than-expected portion of its blockbuster initial public offering to retail investors, according to a person familiar...
One of the largest opportunities in robotics today is autonomous vehicles – large robots that ply our roads carrying people,...
Patterns play out in the stock market. All. The. Time. It’s something you have to know when considering whether the...
Why Old Dominion is more than a freight-cycle story Old Dominion Freight Line (ODFL) often gets treated like a simple...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
